Expression of mucin 1 possessing a 3′-sulfated core1 in recurrent and metastatic breast cancer

International Journal of Cancer

Volumn 137, Issue 7, 2015, Pages 1652-1660

  Ideo, Hiroko ^a,b   Hinoda, Yuji ^c   Sakai, Kohei ^c   Hoshi, Ikue ^a   Yamamoto, Shigeru ^c   Oka, Masaaki ^c   Maeda, Kazunari ^c   Maeda, Noriko ^c   Hazama, Shoichi ^c   Amano, Junko ^b   Yamashita, Katsuko ^a,d  

^a TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^b NOGUCHI INSTITUTE   (Japan)

^c YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

3 sulfated core1; breast cancer; galectin 4; metastasis; MUC1; tumor marker

Indexed keywords

3' SULFATED CORE1 PROTEIN; CA 15-3 ANTIGEN; MUCIN 1; TRANSCRIPTION FACTOR GAL4; TUMOR MARKER; TUMOR PROTEIN; UNCLASSIFIED DRUG; GALECTIN 4; MONOCLONAL ANTIBODY; MUC1 PROTEIN, HUMAN;

ADULT; ANTIGEN DETECTION; ARTICLE; BLOOD FLOW; BREAST CANCER; BREAST CANCER CELL LINE; BREAST CARCINOMA; BREAST METASTASIS; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SECRETION; SENSITIVITY AND SPECIFICITY; SIALYLATION; SURFACE PLASMON RESONANCE; AGED; BIOSYNTHESIS; BLOOD; BREAST TUMOR; CARBOHYDRATE ANALYSIS; CASE CONTROL STUDY; CHEMISTRY; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; PATHOLOGY; TUMOR RECURRENCE;

ADULT; AGED; ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; CARBOHYDRATE SEQUENCE; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GALECTIN 4; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUCIN-1; NEOPLASM RECURRENCE, LOCAL; TUMOR MARKERS, BIOLOGICAL;

EID: 84943389954     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29520     Document Type: Article

References (31)

1. Hilkens J, Buijs F, Hilgers J, et al., Monoclonal antibodies against human milk-fat globule membranes detecting differentiation antigens of the mammary gland and its tumors. Int J Cancer 1984; 34: 197-206.
2. Kufe DW,. Mucins in cancer function, prognosis and therapy. Nat Rev Cancer 2009; 9: 874-5.
3. Perey L, Hayes DF, Maimonis P, et al., Tumor selective reactivity of a monoclonal antibody prepared against a recombinant peptide derived from the DF3 human breast carcinoma-associated antigen. Cancer Res 1992; 52: 2563-8.
4. Taylor-Papadimitriou J, Burchell J, Miles DW, et al., Muc1 and cancer. Biochim Biophys Acta 1999; 1455: 301-13.
5. Hull SR, Bright A, Carraway KL, et al., Oligosaccharide differences in the DF3 sialomucin antigen from normal human milk and the BT-20 human breast carcinoma cell line. Cancer Commun 1989; 1: 261-7.
6. Perey L, Hayes DF, Kufe D,. Effects of differentiating agents on cell surface expression of the breast carcinoma-associated DF3-Pepitope. Cancer Res 1992; 52: 6365-70.
7. Seko A, Ohkura T, Ideo H, et al., Novel O-linked glycans containing 6'-sulfo-gal/GalNAc of MUC1 secreted from human breast cancer YMB-S cells: possible carbohydrate epitopes of KL-6(MUC1) monoclonal antibody. Glycobiology 2012; 22: 181-95.
8. Chandrasekaran EV, Jain RK, Vig R, et al., The enzymatic sulfation of glycoprotein carbohydrate units: blood group T-hapten specific and two other distinct gal: 3-O-sulfotransferases as evident from specificities and kinetics and the influence of sulfate and fucose residues occurring in the carbohydrate chain on C-3 sulfation of terminal Gal. Glycobiology 1997; 7: 753-68.
9. Lau SK, Weiss LM, Chu PG,. Differential expression of MUC1, MUC2, and MUC5Ac in carcinomas of various sites: an immunohistochemical study. Am J Clin Pathol 2004; 122: 61-9.
10. -3Galβ1-3GalNAc pyranoside. Glycobiology 2002; 12: 199-208.
11. Uchida Y, Tsukada Y, Sugimori T,. Production of microbial neuraminidase induced by colominic acid. Biochim Biophy Acta 1974; 350: 425-31.
12. Ideo H, Seko A, Ishizuka I, et al., The N-terminal carbohydrate recognition domain of galectin-8 recognizes specific glycosphingolipids with high affinity. Glycobiology 2003; 13: 713-23.
13. Madersbacher S, Berger P,. Double wavelength measurement of 3,3,5,5′- tetramethylbenzidine (TMB) provides a three-fold enhancement of the ELISA measuring range. J Immunol Methods 1991; 138: 121-4.
14. Zweig MH, Campbell G,. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39: 561-77.
15. R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing 2005. Vienna, Austria. ISBN 3-900051-07-0. Available at: http://www.R-project.org.
16. Sakamoto G, Inaji H, Akiyama F, et al., Japanese breast cancer society. General rules for clinical and pathological recording of breast cancer. Breast Cancer 2005; 12: S1-27.
17. Nozoe T, Oyama T, Mori E, et al., Clinicopathologic significance of an immunohistochemical expression of p27 in scirrhous carcinoma of the breast. Breast Cancer 2007; 14: 277-80.
18. Sönmez H, Süer S, Güngör Z, et al., Tissue and serum sialidase levels in breast cancer. Cancer Lett 1999; 136: 75-8.
19. 3-6Galβ1-4GlcNAc specific lectin in tuberous roots of trichosanthes japonica. Biochemistry 1992; 31: 11647-50.
20. Shibuya N, Goldstein IJ, Broekaert WF, et al., The elderberry (Sambucus Nigra L.) Bark lectin recognizes the Neu5Ac(α2-6) Gal/GalNAc sequence. J Biol Chem 1987; 262: 1596-601.
21. Knibbs RN, Goldstein IJ, Ratcliffe RM, et al., Characterization of the carbohydrate binding specificity of the leukoagglutinating lectin from Maackia amurensis. Comparison with other sialic acid-specific lectins. J Biol Chem 1991; 266: 83-8.
22. Ohkura T, Seko A, Hara-Kuge S, et al., Occurrence of secretory glycoprotein specific GalNAcβ1-4GlcNAc sequence in N-glycans in MDCK cells. J Biochem 2002; 132: 891-901.
23. Ideo H, Seko A, Yamashita K,. Recognition mechanism of galectin-4 for sulfated compounds. J Biol Chem 2007; 282: 21081-9.
24. Tsuji H, Hong JC, Kim YS, et al., Novel carbohydrate specificity of monoclonal antibody 91.9H prepared against human colonic sulfomucin: recognition of sulfo-lewis(a) structure. Biochem Biophys Res Commun 1998; 253: 374-81.
25. Yeh JC, Hiraoka N, Petryniak B, et al., Novel sulfated lymphocyte homing receptors and their control by a core 1 extension beta 1,3-N-acetylglucosaminyltransferase. Cell 2001; 105: 957-69.
26. Kawashima H, Petryniak B, Hiraoka N, et al., N-acetylglucosamine-6-O- sulfotransferases 1 and 2 cooperatively control lymphocyte homing through L-selectin ligand biosynthesis in high endothelial venules. Nat Immunol 2005; 6: 1096-104.
27. Uchimura K, Gauguet JM, Singer MS, et al., A major class of L-selectin ligands is eliminated in mice deficient in two sulfotransferases expressed in high endothelial venules. Nat Immunol 2005; 6: 1105-13.
28. Ideo H, Hoshi I, Yamashita K, et al., Phosphorylation and externalization of galectin-4 is controlled by src family kinases. Glycobiology 2013; 23: 1452-62.
29. Yonezawa S, Goto M, Yamada N, et al., Expression profiles of MUC1, MUC2, and MUC4 mucins in human neoplasms and their relationship with biological behavior. Proteomics 2008; 8: 3329-41.
30. Kohno N, Akiyama M, Kyoizumi S, et al., Detection of soluble tumor-associated antigens in sera and effusion using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma. Jpn J Clin Oncol 1988; 18: 203-16.
31. Goldhirch A, Wood WC, Coates AS, et al., Panel members. Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the st. Gallen international expert consensus on the primary therapy of early breast cancer 2011. Ann Oncol 2011; 22: 1736-47.